AC
RPRX icon

ASB Consultores’s Royalty Pharma RPRX Stock Holding History

ASB Consultores’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,119
Closed -$220K – 121
2025
Q2 		$220K Buy
+6,119
New +$203K 0.15% 132
2024
Q2 		– Sell
-11,798
Closed -$358K – 273
2024
Q1 		$358K Buy
+11,798
New +$348K 0.09% 169
2023
Q3 		– Sell
-9,572
Closed -$294K – 185
2023
Q2 		$294K Buy
9,572
+26
+0.3% +$881 0.14% 134
2023
Q1 		$344K Buy
9,546
+1,465
+18% +$54.3K 0.14% 114
2022
Q4 		$319K Buy
8,081
+2,255
+39% +$94.1K 0.13% 119
2022
Q3 		$234K Hold
5,826
– – 0.11% 150
2022
Q2 		$245K Sell
5,826
-331
-5% -$13.6K 0.11% 134
2022
Q1 		$240K Buy
+6,157
New +$242K 0.1% 184

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return